期刊文献+

冠心病患者血浆中6种神经肽水平的临床研究 被引量:2

Clinical Study of Changes of 6 Kinds of Plasma Neuropeptide Levels in Patients with Coronary Heart Disease
下载PDF
导出
摘要 为了解冠心病患者血浆中6种神经肽(6NP),即神经肽Y(NPY)、降钙素基因相关肽(CGRP)、P物质(SP)、脑啡肽(ENK)、神经降压肽(NT)及血管活性肠肽(VIP)的含量,探讨其在冠心病发病中的临床意义,选择符合WHO诊断标准的急性心肌梗死(AMI)20例、心绞痛(AP)30例,应用放射免疫法动态观察血浆6NP的含量变化,并以30例正常人作对照。结果显示:AMI组发病第1天6NP与对照组比较,差异非常显著(P<0.01),第7、14、21天与第1天比较差异亦非常显著(P<0.05、P<0.01);AP组于心绞痛发作期6NP的含量与对照组比较,差异亦非常显著(P<0.01)。经治疗2周症状缓解后复查血浆6NP含量,皆有不同程度的下降及(或)上升,前后比较有极显著性差异(P<0.01)。结论:血浆6NP的水平与冠心病的严重程度密切相关; In order to study the clinical meaning of plasma levels of 6 kinds of neuropeptide (6NP: NPY,CGRP,SP,ENK,NT and VIP) in patients with coronary heart disease(CHD),the changes of plasma 6NP levels were observed by RIA in 20 patients with acute myocardial infarction (AMI) and 30 patients with angina pectoris(AP) diagnosed according to the WHO diagnosis criteria.The control group included 30 healthy persons.The results showed that campared with normal control group,the levsls of 6NP were different significantly on the 1st day after AMI (P<0.01).The levels of 6NP at the 7th,14th and 21th days after AMI were also different significaltly compared with those in the 1st day after AMI(P<0.05,P<0.01).The 6NP levels in AP group during attack were also different significartly campared with normal control group(P<0.01).After treatment 2 weeks and symptoms relieved,the 6NP levels increased or dicreased significantly (P<0.01).Conclusion:the 6NP might play a role in pathophysiological and pathogenetic mechanism of ClinNeurotensinVasoactive intestinal peptide HD.The severity of the CHD was closely correlated with the 6NP levels.
出处 《标记免疫分析与临床》 CAS 1999年第2期78-81,共4页 Labeled Immunoassays and Clinical Medicine
关键词 急性 心肌梗死 心绞痛 神经肽Y 冠心病 病理 Acute myocardial infarctionAngina pectorisNeuropeptide YCalcitonin gene-related peptideSubstance PEnkepha
  • 相关文献

同被引文献24

  • 1刘世信,张殿文.结肠运输试验对诊断便秘的价值[J].中华医学杂志,1993,73(2):75-77. 被引量:31
  • 2潘世友,丁义江.结肠传输试验的临床应用:附250例X线分析[J].中国肛肠病杂志,1995,15(1):7-9. 被引量:30
  • 3姜若兰.第六讲胃肠激素与胃肠运动[J].中华消化杂志,1996,16(6):353-355. 被引量:59
  • 4陈元芳 陆国钧 等.血管活性肠肽的放射免疫分析[J].中华核医学杂志,1986,6(1):18-18.
  • 5Scheurer U,DrackE,HalterF.Substance P activates rat colonic motility via excitatory and inhibitory neural pathways and direct action on muscles[J].J Pharmacol Exp Ther,1994,271(1):7.
  • 6Arhar P,Deveroede G,Jehannin G,et al.Segmental colonic transit time[J].Dis Colon Rectum,1981,24:625.
  • 7JenssenTG,BurholPG,Jorde R,et al.RIA plasma motilin in man[J].ScandJ Gastroenterrol,1984,19(6):717-723.
  • 8Christofieds ND,BloomSR,Besterman HS.Physiologyof motilin11 [M].In:BloomSR,ED.Gut hormones [M].2 nd ed.Edinburgh:Churchill Livingstone,1978.343-350.
  • 9Wexner SD,Daniel N,Jagelman DG.Colectomy for constipation:Physiologic investigation is the key to succeVIP[J].Dis Colon Rectum,1991,34(10):851.
  • 10Van Assche G,Deportere Ⅰ,Thijs T,et al.Contractile effects and intracellular Ca2+ signaling induced by motilin and erythromycin in the circular smooth muscle of human colon[J].Neurogastroenterol Motil,2001,13(1):27-35.

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部